Letters to the Editor

Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression

Univ Paris Est Creteil, INSERM, IMRB, AP-HP, Hopital Universitaire Henri Mondor, Creteil, France;
Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;
Universite Paris-Sud, Faculte de Medecine Kremlin Bicetre, INSERM UMS33 Villejuif, France;
Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;
Canada Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada;
Dept of Microbiology and Immunology, Michael Smith Laboratories, UBC, Vancouver, BC, Canada;
Department of Microbiology and Immunology, Michael Smith Laboratories, UBC, Vancouver, BC, Canada;
Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;
Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;
Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;
INSERM U935, Hopitaux Universitaires Paris-Sud, AP-HP, Kremlin Bicetre, France;
INSERM UMRS955, Hopital Universitaire Henri Mondor, AP-HP, UPEC, Creteil, France;
INSERM UMRS955, Hopital Universitaire Henri Mondor, AP-HP, UPEC, Creteil, France;
Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;
Canada Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada
Terry Fox Laboratory, British Columbia Cancer, Vancouver, BC, Canada;
Haematologica Early view Jun 4, 2020 https://doi.org/10.3324/haematol.2020.249243